Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Justin M. Balko, Violeta Sánchez et al.|Nature Communications|2016Cited by 572
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Li Ding, Hearn Jay Cho et al.|Cancer Research Communications|2022Cited by 40
Single-Cell RNA-Seq Analysis of CD138-Depleted Bone Marrow Samples Reveals Genetic Alterations and Disease Progression Correlate with Tumor and Bone Marrow Immune Microenvironment in the Mmrf Commpass StudyLijun Yao, Li Ding, Hearn Jay Cho et al.|Blood|2021Cited by 1